Targeted nanomaterials for radiotherapy
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2007/12/01
-
Journal
-
Indian UGC (journal)
-
Refrences58
-
Citations32
-
Freddy E Escorcia Memorial Sloan Kettering Cancer Center, Molecular Pharmacology and Chemistry Program, New York, NY 10021, USA.
-
Michael R McDevitt Memorial Sloan Kettering Cancer Center, Molecular Pharmacology and Chemistry Program, New York, NY 10021, USA.
-
Carlos H Villa Memorial Sloan Kettering Cancer Center, Molecular Pharmacology and Chemistry Program, New York, NY 10021, USA.
-
David A Scheinberg Memorial Sloan Kettering Cancer Center, Molecular Pharmacology and Chemistry Program, New York, NY 10021, USA.
Abstract
Cite
Escorcia, Freddy E, et al. “Targeted Nanomaterials for Radiotherapy”. Nanomedicine, vol. 2, no. 6, 2007, pp. 805-1, https://doi.org/10.2217/17435889.2.6.805.
Escorcia, F. E., McDevitt, M. R., Villa, C. H., & Scheinberg, D. A. (2007). Targeted nanomaterials for radiotherapy. Nanomedicine, 2(6), 805-815. https://doi.org/10.2217/17435889.2.6.805
Escorcia FE, McDevitt MR, Villa CH, Scheinberg DA. Targeted nanomaterials for radiotherapy. Nanomedicine. 2007;2(6):805-1.
Journal Categories
Medicine
Medicine (General)
Technology
Chemical technology
Technology
Chemical technology
Biotechnology
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Technological Advances in Radioimmunotherapy | Clinical Oncology |
| 17 | 2007 |
| p53 Target Gene SMAR1 Is Dysregulated in Breast Cancer: Its Role in Cancer Cell Migration and Invasion | PLOS ONE |
| 50 | 2007 |
| p53 Target Gene SMAR1 Is Dysregulated in Breast Cancer: Its Role in Cancer Cell Migration and Invasion | 2004 | |||
| p53 Target Gene SMAR1 Is Dysregulated in Breast Cancer: Its Role in Cancer Cell Migration and Invasion | Cancer Research |
| 2000 | |
| p53 Target Gene SMAR1 Is Dysregulated in Breast Cancer: Its Role in Cancer Cell Migration and Invasion | 1966 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Injectable Hydrogel for Synergetic Low Dose Radiotherapy, Chemodynamic Therapy and Photothermal Therapy | Frontiers in Bioengineering and Biotechnology |
| 9 | 2021 |
| Hollow Mesoporous Tantalum Oxide Based Nanospheres for Triple Sensitization of Radiotherapy | ACS Applied Materials & Interfaces |
| 23 | 2019 |
| Incorporation of metal free and Ga 5,10,15,20-tetrakis(4-bromophenyl) porphyrin into Pluronic F127-folic acid micelles | Journal of Luminescence |
| 19 | 2018 |
| Effects of Pluronic F127 micelles as delivering agents on the vitro dark toxicity and photodynamic therapy activity of carboxy and pyrene substituted porphyrins | Polyhedron |
| 19 | 2018 |
Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy | Advanced Materials |
| 500 | 2017 |
Citations Analysis
The category
Science: Chemistry 14
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Carbon coated microshells containing nanosized Gd(iii) oxidic phases for multiple bio-medical applications and was published in 2008. The most recent citation comes from a 2021 study titled Injectable Hydrogel for Synergetic Low Dose Radiotherapy, Chemodynamic Therapy and Photothermal Therapy. This article reached its peak citation in 2010, with 7 citations. It has been cited in 30 different journals, 10% of which are open access. Among related journals, the ACS Nano cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.